[{"address1": "Rue Edouard Belin 12", "city": "Mont-Saint-Guibert", "zip": "1435", "country": "Belgium", "phone": "32 10 22 23 55", "website": "https://www.nyxoah.com", "industry": "Medical Instruments & Supplies", "industryKey": "medical-instruments-supplies", "industryDisp": "Medical Instruments & Supplies", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.", "fullTimeEmployees": 146, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert  Taub MBA", "age": 77, "title": "Co-Founder & Chairman", "yearBorn": 1947, "fiscalYear": 2023, "totalPay": 132928, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Olivier  Taelman", "age": 53, "title": "CEO & Executive Director", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 840582, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Loic  Moreau", "age": 44, "title": "President of International", "yearBorn": 1980, "fiscalYear": 2023, "totalPay": 488133, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John  Landry", "age": 51, "title": "Chief Financial Officer", "yearBorn": 1973, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bruno  Onkelinx", "title": "Chief Technology Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mikaela  Kirkwood", "title": "Corporate Communication & Investor Relations Manager", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. An  Moonen", "title": "General Counsel", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Maggie  McGowan", "title": "Chief HR Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Remi  Renard", "title": "Chief of Staff", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeyakumar  Subbaroyan", "title": "Chief Clinical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 10.37, "open": 10.42, "dayLow": 10.36, "dayHigh": 10.88, "regularMarketPreviousClose": 10.37, "regularMarketOpen": 10.42, "regularMarketDayLow": 10.36, "regularMarketDayHigh": 10.88, "beta": 0.548, "forwardPE": -5.882033, "volume": 13940, "regularMarketVolume": 13940, "averageVolume": 44490, "averageVolume10days": 58000, "averageDailyVolume10Day": 58000, "bid": 10.54, "ask": 10.99, "bidSize": 100, "askSize": 100, "marketCap": 404589120, "fiftyTwoWeekLow": 6.76, "fiftyTwoWeekHigh": 20.0, "priceToSalesTrailing12Months": 79.61218, "fiftyDayAverage": 8.66066, "twoHundredDayAverage": 8.83031, "currency": "USD", "enterpriseValue": 324097248, "floatShares": 12152390, "sharesOutstanding": 37427300, "sharesShort": 83481, "sharesShortPriorMonth": 67265, "sharesShortPreviousMonthDate": 1732838400, "dateShortInterest": 1735603200, "sharesPercentSharesOut": 0.0022, "heldPercentInsiders": 0.3832, "heldPercentInstitutions": 0.32432, "shortRatio": 1.73, "shortPercentOfFloat": 0.0039, "impliedSharesOutstanding": 37555800, "bookValue": 3.045, "priceToBook": 3.5500822, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -52980000, "trailingEps": -1.8, "forwardEps": -1.59, "enterpriseToRevenue": 63.774, "enterpriseToEbitda": -6.422, "52WeekChange": -0.12398702, "SandP52WeekChange": 0.23809385, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "NYXH", "underlyingSymbol": "NYXH", "shortName": "Nyxoah SA", "longName": "Nyxoah S.A.", "firstTradeDateEpochUtc": 1619616600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "067cdc20-d2e6-3884-af4a-437fe8703370", "messageBoardId": "finmb_264235912", "gmtOffSetMilliseconds": -18000000, "currentPrice": 10.81, "targetHighPrice": 17.59916, "targetLowPrice": 12.710388, "targetMeanPrice": 15.722351, "targetMedianPrice": 15.650578, "recommendationKey": "none", "numberOfAnalystOpinions": 5, "totalCash": 70977000, "totalCashPerShare": 2.064, "ebitda": -50466000, "totalDebt": 23329000, "quickRatio": 4.824, "currentRatio": 5.283, "totalRevenue": 5082000, "debtToEquity": 22.28, "revenuePerShare": 0.166, "returnOnAssets": -0.23135, "returnOnEquity": -0.49688, "grossProfits": 3139000, "freeCashflow": -35988124, "operatingCashflow": -48709000, "revenueGrowth": 0.297, "grossMargins": 0.61767, "operatingMargins": -11.8325405, "financialCurrency": "EUR", "trailingPegRatio": null, "__fetch_time": "2025-01-25"}]